BCLS Fund III Investments, LP - 30 Jun 2025 SCHEDULE 13G/A Report for DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share (DNTH)

Filing Manager
BCLS Fund III Investments, LP
Reporting Manager
BCLS Fund III Investments, LP
Security
DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share
Symbol
DNTH
Shares outstanding
33,096,667 shares
Disclosed Ownership
2,482,250 shares
Ownership
7.5%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:00:14 UTC
Date of event
30 Jun 2025
Previous filing
14 Feb 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"BCLS Fund III Investments, LP disclosed 7.5% ownership in DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share (DNTH) on 30 Jun 2025."

Quick Takeaways

  • BCLS Fund III Investments, LP filed SCHEDULE 13G/A for DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share (DNTH).
  • Disclosed ownership: 7.5%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 14 Aug 2025, 16:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BCLS Fund III Investments, LP 7.5% 2,482,250 0 2,482,250 /s/ Ricky Sun Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC

Sponsored